References
Criqui MH, Aboyans V (2015) Epidemiology of peripheral artery disease. Circ Res 116:1509–1526. https://doi.org/10.1161/CIRCRESAHA.116.303849
Aboyans V, Ricco J-B, Bartelink M-LEL et al (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J 39:763–816. https://doi.org/10.1093/eurheartj/ehx095
Parmenter BJ, Dieberg G, Smart NA (2015) Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sport Med 45:231–244. https://doi.org/10.1007/s40279-014-0261-z
Parmenter BJ, Dieberg G, Phipps G, Smart NA (2015) Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med 20:30–40. https://doi.org/10.1177/1358863X14559092
Hageman D, Fokkenrood HJ, Gommans LN et al (2018) Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication. Cochrane Database Syst Rev 4:CD005263. https://doi.org/10.1002/14651858.CD005263.pub4
Lamberti N, López-Soto PJ, Guerzoni F et al (2019) Changes in exercise capacity and risk of all-cause mortality in patients with peripheral artery disease: a 10-year retrospective cohort study. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02176-3
Raparelli V, Pastori D, Pignataro SF et al (2018) Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study. Intern Emerg Med. https://doi.org/10.1007/s11739-018-1835-9
Eikelboom JW, Connolly SJ, Bosch J et al (2017) Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 377:1319–1330. https://doi.org/10.1056/NEJMoa1709118
Borges WR, de Carvalho ATY, Junior RA (2017) Predictors of major amputation. Intern Emerg Med 12:1079–1080. https://doi.org/10.1007/s11739-017-1652-6
Anand SS, Caron F, Eikelboom JW et al (2018) Major adverse limb events and mortality in patients with peripheral artery disease: The COMPASS Trial. J Am Coll Cardiol 71:2306–2315. https://doi.org/10.1016/j.jacc.2018.03.008
Huang B-T, Peng Y, Huang F-Y et al (2017) Trends in prescribing rate of statins at discharge and modifiable factors in patients with atherosclerotic cardiovascular disease. Intern Emerg Med 12:1121–1129. https://doi.org/10.1007/s11739-017-1694-9
Kramer MHH, Bauer W, Dicker D et al (2014) The changing face of internal medicine: patient centred care. Eur J Intern Med 25:125–127. https://doi.org/10.1016/j.ejim.2013.11.013
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declare no conflict of interest related to this paper.
Statements on human and animal rights
This article does not contain any studies with human participants or animals performed by the author.
Informed consent
For this type of study, formal consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Proietti, M. Management of peripheral arterial disease in the modern era: an internist “Cup of Tea”. Intern Emerg Med 15, 195–197 (2020). https://doi.org/10.1007/s11739-019-02236-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-019-02236-8